AI/ML Innovations Clarifies Disclosure with Amended MD&A Filing

Vancouver-based AI/ML Innovations Inc. has announced an amended and restated management's discussion and analysis (MD&A) filing for the periods ending January 31, 2025. This amendment addresses disclosure deficiencies identified by the British Columbia Securities Commission. Key enhancements include details on new strategic initiatives, R&D activities, operational results, and recent acquisitions, such as Quantum Sciences Ltd. The report also elaborates on transactions with related parties and the exit agreement with Tech2Heal. Minor housekeeping changes were also incorporated. The Amended MD&A can be accessed on SEDAR+.